Notice: Undefined index: item_type_code in /opt/lampp/htdocs/setiadi5/lib/detail.inc.php on line 462
Sri Bangun Lestari Pengarang Apt. Elly Purwati, S.Si., M.Farm-Klin Dosen Pembimbing 1 Dr. Cikra Ikhda N.H.S, S.Farm., Apt Ketua Penguji Apt. Elly Purwati, S.Si., M.Farm-Klin Penguji 2 Panji Ratih Suci, S.Farm., M.Farm Penguji 1

This study is conducted to determine the antidiabetic drugs prescribing pattern of patients with type 2 diabetes mellitus in internal polyclinic at Sidoarjo’s hospitalfor the period of October-December 2019 following the Guideline: ADA (American Diabetes Association) 2020Standard of Medical Care in Diabetes.This studyis conducted descriptively with the aim of presenting a complete descriptionof a situation objectively using total sampling and retrospective data collection.Thesample in this study take50 sheets of prescription that meet the inclusion criteria and recorded them in the data collector including the name, the dose, and the directions of the medicinethat has been analyzed.Based on the data, it can be concluded that 72% of type 2 DM patients use OAD (Oral Antidiabetic Drugs) treatment therapy.36% single OAD treatment therapy is the preferred choice, OAD of the Biguanide group of 26% is the first-line and preferred initial pharmacological agent.OAD + Insulin treatment therapy is 28%, and the choice of long-acting insulin is 18%, while combination OAD treatment therapy from the Biguanide + Sulfonylurea group is 16%.